An in-depth look to NEXTURNBIOSCIENCE operating, investing, and financing activities

089140 free cash flow for Q3 24 is 109.88 M KRW. For 2023, 089140 free cash flow was -3.05 B KRW and operating cash flow was -1.97 B KRW.